XML 33 R21.htm IDEA: XBRL DOCUMENT
v3.25.3

Business Segment Information | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Business Segment Information | Business Segment Information The Company’s reportable segments are organized based on service platforms, with the Patient Services segment reflecting higher margin rental revenues that generally include payments made by third-party and direct payers and the Device Solutions segment reflecting lower margin product sales, direct payer rental and services revenues. Resources are allocated and performance is assessed for these segments by the Company’s Chief Executive Officer, whom the Company has determined to be its CODM. The CODM uses gross profit for each segment predominantly in the annual budget and forecasting process and considers budget-to-actual variances on a quarterly basis when making operating and capital resource allocation decisions among each segment. The financial information summarized below is presented by reportable segment for the three months ended September 30, 2025 and 2024:
2025 |  |  |  |  |  |  |  |
(in thousands) |  | Patient Services |  | Device Solutions |  | Corporate/ Eliminations |  | Total
Net revenues - external |  | $ | 22,363 |  | $ | 14,125 |  | $ | — |  | $ | 36,488
Net revenues - internal |  | — |  | 1,944 |  | (1,944) |  | —
Total net revenues |  | 22,363 |  | 16,069 |  | (1,944) |  | 36,488
Significant Segment Expenses: |  |  |  |  |  |  |  |
Supplies and material costs |  | 6,141 |  | 4,734 |  | (1,944) |  | 8,931
Employee-related expenses |  | — |  | 4,043 |  | — |  | 4,043
Depreciation |  | 1,841 |  | 917 |  | — |  | 2,758
Other segment items (a) |  | (101) |  | 37 |  | — |  | (64)
Gross profit |  | 14,482 |  | 6,338 |  | — |  | 20,820
Selling, general and administrative expenses |  |  |  |  |  |  |  | 17,009
Interest expense |  |  |  |  |  |  |  | (330)
Other expense |  |  |  |  |  |  |  | (54)
Income before income taxes |  |  |  |  |  |  |  | $ | 3,427
Total assets |  | $ | 50,610 |  | $ | 46,271 |  | $ | 2,000 |  | $ | 98,881
Purchases of medical equipment |  | $ | 618 |  | $ | 409 |  | $ | — |  | $ | 1,027
Depreciation and amortization of intangible assets |  | $ | 2,148 |  | $ | 1,136 |  | $ | — |  | $ | 3,284
(a) Other segment items included in Segment gross profit include estimates for medical equipment considered to be missing and other miscellaneous shop expenses.
2024 |  |  |  |  |  |  |  |
(in thousands) |  | Patient Services |  | Device Solutions |  | Corporate/ Eliminations |  | Total
Net revenues - external |  | $ | 20,780 |  | $ | 14,540 |  | $ | — |  | $ | 35,320
Net revenues - internal |  | — |  | 1,992 |  | (1,992) |  | —
Total net revenues |  | 20,780 |  | 16,532 |  | (1,992) |  | 35,320
Significant Segment Expenses: |  |  |  |  |  |  |  |
Supplies and material costs |  | 5,075 |  | 5,668 |  | (1,992) |  | 8,751
Employee-related expenses |  | — |  | 4,663 |  | — |  | 4,663
Depreciation |  | 1,755 |  | 825 |  | — |  | 2,580
Other segment items (a) |  | 239 |  | 42 |  | — |  | 281
Gross profit |  | 13,710 |  | 5,335 |  | — |  | 19,045
Selling, general and administrative expenses |  |  |  |  |  |  |  | 15,780
Interest expense |  |  |  |  |  |  |  | (476)
Other expense |  |  |  |  |  |  |  | (4)
Income before income taxes |  |  |  |  |  |  |  | $ | 2,785
Total assets |  | $ | 54,821 |  | $ | 48,482 |  | $ | 2,000 |  | $ | 105,303
Purchases of medical equipment |  | $ | 524 |  | $ | 2,842 |  | $ | — |  | $ | 3,366
Depreciation and amortization of intangible assets |  | $ | 2,037 |  | $ | 1,108 |  | $ | — |  | $ | 3,145
(a) Other segment items included in Segment gross profit include estimates for medical equipment considered to be missing and other miscellaneous shop expenses.
The financial information summarized below is presented by reportable segment for the nine months ended September 30, 2025 and 2024:
2025 |  |  |  |  |  |  |  |
(in thousands) |  | Patient Services |  | Device Solutions |  | Corporate/ Eliminations |  | Total
Net revenues - external |  | $ | 64,655 |  | $ | 42,551 |  | $ | — |  | $ | 107,206
Net revenues - internal |  | — |  | 5,597 |  | (5,597) |  | —
Total net revenues |  | 64,655 |  | 48,148 |  | (5,597) |  | 107,206
Significant Segment Expenses: |  |  |  |  |  |  |  |
Supplies and material costs |  | 17,451 |  | 14,085 |  | (5,597) |  | 25,939
Employee-related expenses |  | — |  | 12,774 |  | — |  | 12,774
Depreciation |  | 5,527 |  | 2,794 |  | — |  | 8,321
Other segment items (a) |  | 207 |  | 104 |  | — |  | 311
Gross profit |  | $ | 41,470 |  | $ | 18,391 |  | $ | — |  | $ | 59,861
Selling, general and administrative expenses |  |  |  |  |  |  |  | 51,655
Interest expense |  |  |  |  |  |  |  | (1,039)
Other expense |  |  |  |  |  |  |  | (41)
Income before income taxes |  |  |  |  |  |  |  | $ | 7,126
Total assets |  | $ | 50,610 |  | $ | 46,271 |  | $ | 2,000 |  | $ | 98,881
Purchases of medical equipment |  | $ | 2,887 |  | $ | 2,454 |  | $ | — |  | $ | 5,341
Depreciation and amortization of intangible assets |  | $ | 6,349 |  | $ | 3,596 |  | $ | — |  | $ | 9,945
(a) Other segment items included in Segment gross profit include estimates for medical equipment considered to be missing and other miscellaneous shop expenses.
2024 |  |  |  |  |  |  |  |
(in thousands) |  | Patient Services |  | Device Solutions |  | Corporate/ Eliminations |  | Total
Net revenues - external |  | $ | 59,617 |  | $ | 41,396 |  | $ | — |  | $ | 101,013
Net revenues - internal |  | — |  | 5,447 |  | (5,447) |  | —
Total net revenues |  | 59,617 |  | 46,843 |  | (5,447) |  | 101,013
Significant Segment Expenses: |  |  |  |  |  |  |  |
Supplies and material costs |  | 14,811 |  | 16,927 |  | (5,447) |  | 26,291
Employee-related expenses |  | — |  | 14,642 |  | — |  | 14,642
Depreciation |  | 5,011 |  | 2,386 |  | — |  | 7,397
Other segment items (a) |  | 366 |  | 130 |  | — |  | 496
Gross profit |  | $ | 39,428 |  | $ | 12,759 |  | $ | — |  | $ | 52,187
Selling, general and administrative expenses |  |  |  |  |  |  |  | 47,912
Interest expense |  |  |  |  |  |  |  | (1,416)
Other expense |  |  |  |  |  |  |  | (64)
Income before income taxes |  |  |  |  |  |  |  | $ | 2,795
Total assets |  | $ | 54,821 |  | $ | 48,482 |  | $ | 2,000 |  | $ | 105,303
Purchases of medical equipment |  | $ | 4,339 |  | $ | 7,823 |  | $ | — |  | $ | 12,162
Depreciation and amortization of intangible assets |  | $ | 5,852 |  | $ | 3,226 |  | $ | — |  | $ | 9,078
(a) Other segment items included in Segment gross profit include estimates for medical equipment considered to be missing and other miscellaneous shop expenses.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 12: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 14: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 16: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration